160 related articles for article (PubMed ID: 20361286)
1. Tumor markers AFP, CA 125, and CA 19-9 in the long-term follow-up of sacrococcygeal teratomas in infancy and childhood.
Pauniaho SL; Tatti O; Lahdenne P; Lindahl H; Pakarinen M; Rintala R; Heikinheimo M
Tumour Biol; 2010 Aug; 31(4):261-5. PubMed ID: 20361286
[TBL] [Abstract][Full Text] [Related]
2. Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors.
Lahdenne P; Pitkänen S; Rajantie J; Kuusela P; Siimes MA; Lanning M; Heikinheimo M
Pediatr Res; 1995 Nov; 38(5):797-801. PubMed ID: 8552451
[TBL] [Abstract][Full Text] [Related]
3. Half-life of alpha-fetoprotein in neonatal sacrococcygeal teratoma.
Nam SH; Cho MJ; Kim DY; Kim SC
J Pediatr Surg; 2018 Dec; 53(12):2470-2474. PubMed ID: 30249359
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of serum alpha-fetoprotein levels in diagnosing recurrent sacrococcygeal teratoma: A systematic review.
van Heurn LJ; Knipscheer MM; Derikx JPM; van Heurn LWE
J Pediatr Surg; 2020 Sep; 55(9):1732-1739. PubMed ID: 32376010
[TBL] [Abstract][Full Text] [Related]
5. Sacrococcygeal yolk sac tumor developing after teratoma: a clinicopathological study of pediatric sacrococcygeal germ cell tumors and a proposal of the pathogenesis of sacrococcygeal yolk sac tumors.
Yoshida M; Matsuoka K; Nakazawa A; Yoshida M; Inoue T; Kishimoto H; Nakayama M; Takaba E; Hamazaki M; Yokoyama S; Horie H; Tanaka M; Gomi K; Ohama Y; Kigasawa H; Kitano Y; Uchida H; Kanamori Y; Iwanaka T; Tanaka Y
J Pediatr Surg; 2013 Apr; 48(4):776-81. PubMed ID: 23583133
[TBL] [Abstract][Full Text] [Related]
6. Congenital teratoma: a clinicopathologic study of 22 fetal and neonatal tumors.
Heerema-McKenney A; Harrison MR; Bratton B; Farrell J; Zaloudek C
Am J Surg Pathol; 2005 Jan; 29(1):29-38. PubMed ID: 15613854
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of tumor markers in ovarian mature cystic teratoma.
Chen JM; Gao HY; Wang Q; Li Q
Clin Exp Obstet Gynecol; 2016; 43(3):397-400. PubMed ID: 27328499
[TBL] [Abstract][Full Text] [Related]
8. Sacrococcygeal teratoma: late recurrence warrants long-term surveillance.
Padilla BE; Vu L; Lee H; MacKenzie T; Bratton B; O'Day M; Derderian S
Pediatr Surg Int; 2017 Nov; 33(11):1189-1194. PubMed ID: 28894920
[TBL] [Abstract][Full Text] [Related]
9. Malignant sacrococcygeal germ cell tumors in children in Taiwan: A retrospective single-center case series.
Chen SH; Du CJ; Lai JY; Chang TY; Yang CP; Hung IJ; Jaing TH; Ming YC; Hsueh C
Medicine (Baltimore); 2021 Jan; 100(4):e24323. PubMed ID: 33530223
[TBL] [Abstract][Full Text] [Related]
10. Unusual presentation of sacrococcygeal teratomas and associated malformations in children: clinical experience and review of the literature.
Paradies G; Zullino F; Orofino A; Leggio S
Ann Ital Chir; 2013; 84(3):333-46. PubMed ID: 23160138
[TBL] [Abstract][Full Text] [Related]
11. Sacrococcygeal teratomas: a review of 68 cases.
Valdiserri RO; Yunis EJ
Cancer; 1981 Jul; 48(1):217-21. PubMed ID: 6165455
[TBL] [Abstract][Full Text] [Related]
12. Malignant recurrence after mature Sacrococcygeal teratoma: A meta-analysis and review of the literature.
Kops AL; Hulsker CC; Fiocco M; Zsiros J; Mavinkurve-Groothuis AMC; Looijenga LH; van der Steeg AF; Wijnen MH
Crit Rev Oncol Hematol; 2020 Dec; 156():103140. PubMed ID: 33142194
[TBL] [Abstract][Full Text] [Related]
13. Sacrococcygeal teratoma with intradural extension: case report.
Shahjouei S; Hanaei S; Nejat F; Monajemzadeh M; Khashab ME
J Neurosurg Pediatr; 2015 Apr; 15(4):380-3. PubMed ID: 25612665
[TBL] [Abstract][Full Text] [Related]
14. Alpha-fetoprotein levels correlate with the pathologic grade and surgical outcomes of pediatric retroperitoneal teratomas.
Hunter CJ; Ford HR; Estrada JJ; Stein JE
Pediatr Surg Int; 2009 Apr; 25(4):331-6. PubMed ID: 19198853
[TBL] [Abstract][Full Text] [Related]
15. Variability in Surveillance Strategies Following Resection of Sacrococcygeal Teratoma.
Gil LA; Knaus ME; Stanek JR; Srivatsa S; Patterson KN; Wood RJ; Minneci PC; Ranalli MA; Aldrink JH
J Surg Res; 2024 Mar; 295():423-430. PubMed ID: 38070256
[TBL] [Abstract][Full Text] [Related]
16. Maternal serum alpha-fetoprotein and epithelial tumour marker concentrations are not increased by fetal sacrococcygeal teratoma.
Kirkinen P; Heinonen S; Vanamo K; Ryynänen M
Prenat Diagn; 1997 Jan; 17(1):47-50. PubMed ID: 9021828
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89.
Calaminus G; Schneider DT; Bökkerink JP; Gadner H; Harms D; Willers R; Göbel U
J Clin Oncol; 2003 Mar; 21(5):781-6. PubMed ID: 12610174
[TBL] [Abstract][Full Text] [Related]
18. [Malignant recurrence of "mature" sacrococcygeal teratoma. A clinicopathological study of 4 cases].
Njim L; Moussa A; Ziadi J; Dhouibi A; Maazoon K; Zakhama A
Rev Med Liege; 2011 Jan; 66(1):25-9. PubMed ID: 21374957
[TBL] [Abstract][Full Text] [Related]
19. Biphasic reduction and concanavalin A binding properties of serum alpha-fetoprotein in preterm and term infants.
Lahdenne P; Kuusela P; Siimes MA; Rönnholm KA; Salmenperä L; Heikinheimo M
J Pediatr; 1991 Feb; 118(2):272-6. PubMed ID: 1704432
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome for infants and children with sacrococcygeal teratoma: a report from the Childrens Cancer Group.
Rescorla FJ; Sawin RS; Coran AG; Dillon PW; Azizkhan RG
J Pediatr Surg; 1998 Feb; 33(2):171-6. PubMed ID: 9498381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
